Venous Thromboembolism: all 708 studies
Page 5 of 8. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityCompletedNCT04153760Early Phase 1
- Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism.Status unknownNCT04141254Phase 3
- A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the USCompletedNCT04141228
- Thrombus Elastography in Venous Thrombo-Embolism.Status unknownNCT04130048
- A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE)Status unknownNCT04128254Phase 4
- Risk of Recurrent Venous Thromboembolism After Provoked Venous ThromboembolismStatus unknownNCT04124159
- Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell TumoursCompletedNCT04122430
- Risk Factors for Thrombosis in Children With Central Venous LinesCompletedNCT04117217
- Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDsTerminatedNCT04106700Phase 2
- VTE Prevention Following Total Hip and Knee ArthroplastyCompletedNCT04075240Phase 3
- Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic TherapyCompletedNCT04072068Phase 4
- LEAVE Safe With DOACsCompletedNCT04068727Not applicable
- Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.CompletedNCT04064489Not applicable
- Oral Anticoagulant Apixaban for Treatment of Venous ThromboembolismCompletedNCT04041843Phase 2
- Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot StudyWithdrawnNCT03988231Phase 4
- Role of Statin in Venous Dysfunction in Patients With Venous Thromboembolism EventCompletedNCT03988101Phase 4
- Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome AnalysisCompletedNCT03977870
- The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)TerminatedNCT03977363
- Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood ThinnersCompletedNCT03965741
- Longitudinal Hemostatic Profile After Stopping Estroprogestative ContraceptivesCompletedNCT03949985
- A Two-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-7684 in Healthy Adult VolunteersCompletedNCT03919890Phase 1
- LIFE - Lung Cancer, Immunotherapy, Frailty, EffectActive, not recruitingNCT03870464
- Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous ThromboembolismStatus unknownNCT03802929
- An Observational Study on Incidence, Natural History and Treatment Patterns of Venous Thromboembolism in TaiwanCompletedNCT03799016
- Risk Prediction of Venous Thromboembolism in Critically IllStatus unknownNCT03773939
- Genital Haemorrhage in Woman of Childbearing Age Treated for Venous Thromboembolism Disease : Comparison According to Oral Anticoagulant and Impact on Quality of LifeActive, not recruitingNCT03772366
- Safety and Efficacy Study of Fitaya Vena Cava FilterStatus unknownNCT03691753Not applicable
- Apixaban for Extended Anticoagulation (APIDULCIS)TerminatedNCT03678506Phase 4
- Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo TransferCompletedNCT03660007
- Venous Thromboembolism and Bleeding Risk in Patients With Esophageal CancerCompletedNCT03646409
- Venous Thromboembolism in Advanced Lung CancerStatus unknownNCT03581708
- Risk Factors and Outcomes of Acute Venous Thromboembolism in CirrhoticStatus unknownNCT03580577
- Allo - Cancer - ThrombosisStatus unknownNCT03563924
- Venous Thrombo-embolic Complication prévention in Pelvic SurgeryCompletedNCT03535428
- Coagulation After Intravenous Methylprednisolone AdministrationCompletedNCT03535090
- Rivaroxaban as Thrombosis Prophylaxis in Bariatric SurgeryCompletedNCT03522259Phase 2
- A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood ClotCompletedNCT03521908
- Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based HeparinCompletedNCT03516656Early Phase 1
- Retrospective Evaluation of Thrombo-embolic Complication in Pelvic Fracture SurgeryCompletedNCT03475771
- Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin MonitoringStatus unknownNCT03426982Phase 4
- Venous Thromboembolism in Myotonic Dystrophy Type 1CompletedNCT03424460Not applicable
- Validation of the 4TS RAM in the Prevention of Venous Thromboembolism in Patients With Plasma Cell Dyscrasias.Status unknownNCT03405571
- Monotherapy Anticoagulation To Expedite Home Treatment of Venous ThromboembolismCompletedNCT03404635
- Hemostatic Profiles of Endocrine Therapies for Breast CancerCompletedNCT03381963
- Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE ProphylaxisCompletedNCT03367364Not applicable
- Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral ContraceptivesCompletedNCT03309293Not applicable
- WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous ThromboembolismTerminatedNCT03297359Phase 2
- Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism StudyCompletedNCT03292666
- REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.CompletedNCT03285438Phase 3
- Distribution of Risk Factors for Venous Thromboembolism in Blood DonorsCompletedNCT03282747
- Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPDStatus unknownNCT03277001Not applicable
- FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee ArthroplastyCompletedNCT03276143Phase 2
- Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous ThrombosisStatus unknownNCT03265054
- Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical PatientsCompletedNCT03243708Not applicable
- A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous ThromboembolismStatus unknownNCT03240120Phase 3
- Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With RivaroxabanCompletedNCT03214172
- Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord InjuryTerminatedNCT03200613Phase 2
- Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal FunctionCompletedNCT03158792Phase 4
- Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine WardsStatus unknownNCT03157843
- Venous Thromboembolism in DM1CompletedNCT03141749
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Time of Treatment With LMWH in Cancer Patients With Thromboembolic DiseaseCompletedNCT03134820
- Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical PatientsCompletedNCT03124017Not applicable
- Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal ResectionCompletedNCT03115541
- Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)CompletedNCT03099031
- Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)TerminatedNCT03090880Phase 3
- Treatment of Venous Thromboembolism in Real-Life PatientsCompletedNCT03087474
- Drug Interaction Study of Apixaban With Cyclosporine and TacrolimusCompletedNCT03083782Phase 1
- Timing of VTE Prophylaxis in TBIWithdrawnNCT03081169Phase 4
- RIPT Feasibility TrialCompletedNCT03070834Not applicable
- Thrombosis Outcomes in Pediatric Venous ThromboembolismCompletedNCT03068923
- Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.CompletedNCT03055026Phase 3
- Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )CompletedNCT03054727
- Microsurgical Breast Reconstruction & VTECompletedNCT03031457
- VTE Prophylaxis Guidelines in Hospitalized EldersCompletedNCT03025100
- SToP: Venous Thromboembolism Screening in the Trauma PopulationStatus unknownNCT02978950Not applicable
- Patient Safety Learning Laboratory: Making Acute Care More Patient-CenteredCompletedNCT02969343Not applicable
- Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)CompletedNCT02952599
- Edoxaban Management in Diagnostic and Therapeutic ProceduresCompletedNCT02950168
- Apixaban for Routine Management of Upper Extremity Deep Venous ThrombosisTerminatedNCT02945280Phase 4
- Thromboprophylaxis After Surgery for Gynecologic Malignancy in ChinaCompletedNCT02935530Phase 3
- Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy ParticipantsCompletedNCT02912234Phase 1
- Multiple Algorithms System Of All Scores in Embolism (MOSE)Status unknownNCT02911012
- Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole GenomeCompletedNCT02904967Not applicable
- Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision AlgorithmWithdrawnNCT02900404
- Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant PrescriptionsCompletedNCT02898090
- Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous ThromboembolismStatus unknownNCT02898051
- Incidence of Venous Thromboembolism and Professional Practices in Brest AreaCompletedNCT02895971
- Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic DiseaseStatus unknownNCT02877251
- Anticoagulation Medical HomeCompletedNCT02870296Not applicable
- Self-management of Anticoagulation TreatmentCompletedNCT02864537Not applicable
- anti10a Levels in Women Treated With LMWH in the Postpartum PeriodCompletedNCT02856295Phase 4
- Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of LungCompletedNCT02853188Not applicable
- ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTECompletedNCT02836457
- Direct Oral Anticoagulants and Venous ThromboembolismCompletedNCT02833987
- PK of Rivaroxaban in Bariatric Patients - ExtensionCompletedNCT02832947Phase 1
- RIVET - Retrospective Cohort Study on the Risk of Venous ThromboembolismCompletedNCT02828904
- Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee ReplacementCompletedNCT02810704Phase 4
- Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU PatientsCompletedNCT02795065Not applicable
- Cancer Associated Thrombosis, a Pilot Treatment Study Using RivaroxabanCompletedNCT02746185Phase 3